Abstract
The solubility behavior of the pharmaceutical materials in a supercritical fluid is very important to produce the micro/nano-sized drug particulates. In the current study, solubility of montelukast as a potential treatment of COVID-19, in supercritical carbon dioxide (SC-CO2) was considered under different sets of temperature (308–338 K) and pressure (12–30 MPa). The obtained solubilities were in the range of 0.4 × 10-6 to 6.12 × 10-5 at (338 K, 12 MPa) and (338 K, 30 MPa), respectively. Two approaches i) empirical equations (i.e., Sodeifian et al., Bartle et al., Chrastil and Bian et al., Mendez-SantiagoandTeja(MST) and Jouyban et al. and ii) equations of state (i.e., Peng-Robinson (PR)) combined with van der Waals (vdW2) mixing rules, SAFT-VR Mie were applied to correlate the experimental solubility data. According to the results, it could be concluded that Chrastil and Bartle et al. models produced the best correlations with the average absolute relative deviation % of 10.28 and 10.81, respectively. In addition, PR and SAFT-VR Mie EoS could provide satisfactory results for SC-CO2 solubility of montelukast at 308 to 338 K. Eventually, the results were devised to estimate the vaporization (ΔHvap), solvation (ΔHsol) and total enthalpies (ΔHtotal) of the solution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
